Literature DB >> 21406032

Anal sex, vaginal practices, and HIV incidence in female sex workers in urban Kenya: implications for the development of intravaginal HIV prevention methods.

Frances H Priddy1, Sabina Wakasiaka, Tina D Hoang, Donna J Smith, Bashir Farah, Carlos del Rio, Jeckoniah Ndinya-Achola.   

Abstract

Multiple intravaginal HIV prevention methods, including microbicide gels, barriers, and intravaginal rings, are in clinical development in Africa. Development of intravaginal HIV prevention products requires an understanding of sexual behavior, sexually transmitted infection (STI), and vaginitis prevalences, and sexual and vaginal practices in potential target populations. We assessed these factors in a cohort of Kenyan female sex workers (FSW). Women who reported exchanging sex for money/gifts at least three times in the past month and who were HIV uninfected were enrolled and followed for 6 months. STI prevalence and HIV incidence were analyzed by multivariate logistic regression analysis, controlling for demographic and behavioral factors. Thirty-seven percent (74/200) reported having had anal sex. Frequency of anal sex was higher with regular and casual partners than with primary partners. Women were less likely to use condoms for anal sex than for vaginal sex with regular or casual partners. Vaginal washing was universal (100%). HIV incidence was 5.6 per 100 person-years (95% CI 1.62, 11.67). HIV incidence was not associated with any demographic or risk behavior. The relatively high rate of anal sex and universal vaginal washing may complicate both safety and efficacy evaluation of intravaginal products and should be taken into account in trial design. This FSW population had significant HIV incidence and needs continued HIV prevention interventions.

Entities:  

Mesh:

Year:  2011        PMID: 21406032      PMCID: PMC3186689          DOI: 10.1089/aid.2010.0362

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  23 in total

1.  Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies.

Authors:  Ian McGowan; Douglas J Taylor
Journal:  Sex Transm Dis       Date:  2010-06       Impact factor: 2.830

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

Review 3.  Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms.

Authors:  Landon Myer; Louise Kuhn; Zena A Stein; Thomas C Wright; Lynette Denny
Journal:  Lancet Infect Dis       Date:  2005-12       Impact factor: 25.071

4.  Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, Kenya.

Authors:  M Schwandt; C Morris; A Ferguson; E Ngugi; S Moses
Journal:  Sex Transm Infect       Date:  2006-06-21       Impact factor: 3.519

5.  Effect of intravaginal practices on the vaginal and cervical mucosa of Zimbabwean women.

Authors:  J H van de Wijgert; Z M Chirenje; V Iliff; M T Mbizvo; P R Mason; L Gwanzura; S Shiboski; N S Padian
Journal:  J Acquir Immune Defic Syndr       Date:  2000-05-01       Impact factor: 3.731

6.  Recommendations for the clinical development of topical microbicides: an update.

Authors:  C Mauck; Z Rosenberg; L Van Damme
Journal:  AIDS       Date:  2001-05-04       Impact factor: 4.177

7.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

8.  Rectal microbicides.

Authors:  Ian McGowan; Peter Anton
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

9.  Cofactors in male-female sexual transmission of human immunodeficiency virus type 1.

Authors:  F A Plummer; J N Simonsen; D W Cameron; J O Ndinya-Achola; J K Kreiss; M N Gakinya; P Waiyaki; M Cheang; P Piot; A R Ronald
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

Review 10.  A systematic review of published evidence on intervention impact on condom use in sub-Saharan Africa and Asia.

Authors:  A M Foss; M Hossain; P T Vickerman; C H Watts
Journal:  Sex Transm Infect       Date:  2007-10-11       Impact factor: 3.519

View more
  28 in total

1.  An effective intervention to reduce intravaginal practices among HIV-1 uninfected Kenyan women.

Authors:  Sumathi Sivapalasingam; R Scott McClelland; Jacques Ravel; Aabid Ahmed; Charles M Cleland; Pawel Gajer; Musa Mwamzaka; Fatma Marshed; Juma Shafi; Linnet Masese; Mark Fajans; Molly E Anderson; Walter Jaoko; Ann E Kurth
Journal:  AIDS Res Hum Retroviruses       Date:  2014-09-29       Impact factor: 2.205

2.  Examining targets for HIV prevention: intravaginal practices in Urban Lusaka, Zambia.

Authors:  Maria L Alcaide; Maureen Chisembele; Miriam Mumbi; Emeria Malupande; Deborah Jones
Journal:  AIDS Patient Care STDS       Date:  2014-02-25       Impact factor: 5.078

3.  Recruitment of Female Sex Workers in HIV Prevention Trials: Can Efficacy Endpoints Be Reached More Efficiently?

Authors:  Daniel Wood; Kathryn E Lancaster; Marie-Claude Boily; Kimberly A Powers; Deborah Donnell; Myron S Cohen; Dobromir T Dimitrov
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

4.  Sexual Behavior and Vaginal Practices During Pregnancy and Postpartum: Implications for HIV Prevention Strategies.

Authors:  John Kinuthia; Barbra A Richardson; Alison L Drake; Daniel Matemo; Jennifer A Unger; Raymond S McClelland; Grace John-Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

5.  Intravaginal practices among HIV-negative female sex workers along the US-Mexico border and their implications for emerging HIV prevention interventions.

Authors:  Dominika Seidman; Melanie Rusch; Daniela Abramovitz; Jamila K Stockman; Gustavo Martinez; Gudelia Rangel; Alicia Vera; Monica D Ulibarri; Steffanie A Strathdee
Journal:  Int J Gynaecol Obstet       Date:  2016-01-28       Impact factor: 3.561

6.  Condoms, Lubricants and Rectal Cleansing: Practices Associated with Heterosexual Penile-Anal Intercourse Amongst Participants in an HIV Prevention Trial in South Africa, Uganda and Zimbabwe.

Authors:  Zoe Duby; Miriam Hartmann; Elizabeth T Montgomery; Christopher J Colvin; Barbara Mensch; Ariane van der Straten
Journal:  AIDS Behav       Date:  2016-04

7.  Prevalence of HIV, sexually transmitted infections, and risk behaviours among female sex workers in Nairobi, Kenya: results of a respondent driven sampling study.

Authors:  Helgar Musyoki; Timothy A Kellogg; Scott Geibel; Nicholas Muraguri; Jerry Okal; Waimar Tun; H Fisher Raymond; Sufia Dadabhai; Meredith Sheehy; Andrea A Kim
Journal:  AIDS Behav       Date:  2015-02

8.  Oral and vaginal HIV pre-exposure prophylaxis product attribute preferences among female sex workers in the Mexico-US border region.

Authors:  H A Pines; S A Strathdee; C W Hendrix; C C Bristow; A Harvey-Vera; C Magis-Rodríguez; G Martinez; S J Semple; T L Patterson
Journal:  Int J STD AIDS       Date:  2018-08-31       Impact factor: 1.359

9.  HIV transmission: time for translational studies to bridge the gap.

Authors:  Peter Anton; Betsy C Herold
Journal:  Sci Transl Med       Date:  2011-04-06       Impact factor: 17.956

10.  Factors associated with risky sexual practices among female sex workers in Karnataka, India.

Authors:  Bidhubhusan Mahapatra; Catherine M Lowndes; Sanjay Kumar Mohanty; Kaveri Gurav; Banadakoppa M Ramesh; Stephen Moses; Reynold Washington; Michel Alary
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.